Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer’s Disease and Future Perspectives

Alzheimer’s disease (AD) is a slowly progressive neurodegenerative disease conceptualized as a continuous process, ranging from mild cognitive impairment (MCI), to the mild, moderate, and severe clinical stages of AD dementia. AD is considered a complex multifactorial disease. Currently, the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreira, Natália Chermont dos Santos, Lima, Jéssica Ellen Barbosa de Freitas, Marchiori, Marcelo Fiori, Carvalho, Ivone, Sakamoto-Hojo, Elza Tiemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108627/
https://www.ncbi.nlm.nih.gov/pubmed/35591949
http://dx.doi.org/10.3233/ADR-210061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108627/
https://www.ncbi.nlm.nih.gov/pubmed/35591949
http://dx.doi.org/10.3233/ADR-210061

Ejemplares similares